Clémentine Lesbats

Clémentine Lesbats

Auto-generated profile, based on publicly available information

Clémentine Lesbats

Sir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2013 in Experimental Neurology
Verified
Journal Article
Closed access
FTFei Teng
Fei Teng
VBVirginie Beray-Berthat
Virginie Beray-Berthat
BCBérard Coqueran
Bérard Coqueran
CLClémentine Lesbats
Clémentine Lesbats
MKMélanie Kuntz
Mélanie Kuntz
IMIsabelle Margaill
Isabelle Margaill

9 March 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Nicola J. RogersNicola J. Rogers
Nicola J. Rogers
FHfraser hill-casey
fraser hill-casey
KSKarl F. Stupic
Karl F. Stupic
JSJoseph S. Six
Joseph S. Six
CLClémentine Lesbats
Clémentine Lesbats
TMThomas Meersmann
Thomas Meersmann
Significance: The high signal intensity associated with magnetic resonance of hyperpolarized129Xe has enabled countless applications ranging from materials science to biomedical MRI of the lung and brain. New modalities are constantly emerging; for example, hyperpolarized129Xe biosensors are of potential interest for molecular imaging of biomarker distribution in organs. Hyperpolarized83Kr shows promise as novel surface-sensitive contrast agent for pulmonary MRI but previous work was limited to excised lungs. This work reports a previously unexplored approach in the generation of hyperpolarized contrast agents that makes highly concentrated hyperpolarized83Kr available for the first time, to our knowledge. The results also provide the basis for on-demand flow production of highly concentrated hyperpolarized129Xe for in situ process monitoring and in vivo molecular imaging.

28 October 2015 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
DLDavid M.L. Lilburn
David M.L. Lilburn
ATAmanda L. Tatler
Amanda L. Tatler
JSJoseph S. Six
Joseph S. Six
CLClémentine Lesbats
Clémentine Lesbats
AHAnthony Habgood
Anthony Habgood
TMThomas Meersmann
Thomas Meersmann
Purpose: Asthma is a disease of increasing worldwide importance that calls for new investigative methods. Ex vivo lung tissue is being increasingly used to study functional respiratory parameters independent of confounding systemic considerations but also to reduce animal numbers and associated research costs. In this work, a straightforward laboratory method is advanced to probe dynamic changes in gas inhalation patterns by using an ex vivo small animal ovalbumin (OVA) model of human asthma.Methods: Hyperpolarized (hp)129Xe was actively inhaled by the excised lungs exposed to a constant pressure differential that mimicked negative pleural cavity pressure. The method enabled hp129Xe MRI of airway responsiveness to intravenous methacholine (MCh) and airway challenge reversal through salbutamol.Results: Significant differences were demonstrated between control and OVA challenged animals on global lung hp129Xe gas inhalation withP < 0.05 at MCh dosages above 460 μg. Spatial mapping of the regional hp gas distribution revealed an approximately three‐fold increase in heterogeneity for the asthma model organs.Conclusion: The experimental results from this proof of concept work suggest that the ex vivo hp noble gas imaging arrangement and the applied image analysis methodology may be useful as an adjunct to current diagnostic techniques. Magn Reson Med 76:1224–1235, 2016. © 2015 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

17 June 2015 in Chemphyschem
Verified
Journal Article
Closed access
PDF file
FZFrancesco Zamberlan
Francesco Zamberlan
CLClémentine Lesbats
Clémentine Lesbats
Nicola J. RogersNicola J. Rogers
Nicola J. Rogers
JKJames L. Krupa
James L. Krupa
GPGalina E. Pavlovskaya
Galina E. Pavlovskaya
TMThomas Meersmann
Thomas Meersmann

11 October 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ATAlexander J. Taylor
Alexander J. Taylor
JGJosef Granwehr
Josef Granwehr
CLClémentine Lesbats
Clémentine Lesbats
JKJames L. Krupa
James L. Krupa
JSJoseph S. Six
Joseph S. Six
HFHenryk M. Faas
Henryk M. Faas
Due to low fluorine background signal in vivo, 19F is a good marker to study the fate of exogenous molecules by magnetic resonance imaging (MRI) using equilibrium nuclear spin polarization schemes. Since 19F MRI applications require high sensitivity, it can be important to assess experimental feasibility during the design stage already by estimating the minimum detectable fluorine concentration. Here we propose a simple method for the calibration of MRI hardware, providing sensitivity estimates for a given scanner and coil configuration. An experimental “calibration factor” to account for variations in coil configuration and hardware set-up is specified. Once it has been determined in a calibration experiment, the sensitivity of an experiment or, alternatively, the minimum number of required spins or the minimum marker concentration can be estimated without the need for a pilot experiment. The definition of this calibration factor is derived based on standard equations for the sensitivity in magnetic resonance, yet the method is not restricted by the limited validity of these equations, since additional instrument-dependent factors are implicitly included during calibration. The method is demonstrated using MR spectroscopy and imaging experiments with different 19F samples, both paramagnetically and susceptibility broadened, to approximate a range of realistic environments.

10 November 2022 in NMR in Biomedicine
Verified
Journal Article
Open access
SBSOURAV BHADURI
SOURAV BHADURI
CKClaire Louise Kelly
Claire Louise Kelly
CLClémentine Lesbats
Clémentine Lesbats
JSJack Sharkey
Jack Sharkey
LRLorenzo Ressel
Lorenzo Ressel
HPHarish Poptani
Harish Poptani
Changes in glioblastoma (GBM) metabolism was investigated in response to JAS239, a choline kinase inhibitor, using MRS. In addition to the inhibition of phosphocholine synthesis, we investigated changes in other key metabolic pathways associated with GBM progression and treatment response. Three syngeneic rodent models of GBM were used: F98 (N = 12) and 9L (N = 8) models in rats and GL261 (N = 10) in mice. Rodents were intracranially injected with GBM cells in the right cortex and tumor growth was monitored using T2‐weighted images. Animals were treated once daily with intraperitoneal injections of 4 mg/kg JAS239 (F98 rats, n = 6; 9L rats, n = 6; GL261 mice, n = 5) or saline (control group, F98 rats, n = 6; 9L rats, n = 2; GL261 mice, n = 5) for five consecutive days. Single voxel spectra were acquired on Days 0 (T0, baseline) and 6 (T6, end of treatment) from the tumor as well as the contralateral normal brain using a PRESS sequence. Changes in metabolite ratios (tCho/tCr, tCho/NAA, mI/tCr, Glx/tCr and (Lip + Lac)/Cr) were used to assess metabolic pathway alterations in response to JAS239. Tumor growth arrest was noted in all models in response to JAS239 treatment compared with saline‐treated animals, with a significant reduction (p < 0.05) in the F98 model. A reduction in tCho/tCr was observed with JAS239 treatment in all GBM models, indicating reduced phospholipid metabolism, with the highest reduction in 9L followed by GL261 and F98 tumors. A significant reduction (p < 0.05) in the tCho/NAA ratio was observed in the 9L model. A significant reduction in mI/tCr (p < 0.05) was found in JAS239‐treated F98 tumors compared with the saline‐treated animals. A non‐significant trend of reduction in Glx/tCr was observed only in F98 and 9L tumors. JAS239‐treated F98 tumors also showed a significant increase in Lip + Lac (p < 0.05), indicating increased cell death. This study demonstrated the utility of MRS in assessing metabolic changes in GBM in response to choline kinase inhibition.